MTOR and cancer: Silencing RICTOR indeed inhibited AKT activity indicated by Ser473 phosphorylation; however, supporting the observations in muscle cells36 and cancer cells37, we found in HAEC that AKT activity was never inhibited by the interference of mTOR to disrupt mTORC1/2.